Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follo (Q52841221)
Jump to navigation
Jump to search
scientific article published on 24 July 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follo |
scientific article published on 24 July 2013 |
Statements
Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follo (English)
Theo M de Reijke
Laurence Collette
Urs E Studer
Peter Whelan
Florian Wimpissinger
Jacques Casselman
Hartmut Knönagel
Wolfgang Loidl
Santiago Isorna
Subramanian K Sundaram
EORTC Genitourinary Cancer Group
24 July 2013
66
5
829-838